These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 31717683)

  • 1. In Vitro Activity of Sertraline, an Antidepressant, Against Antibiotic-Susceptible and Antibiotic-Resistant
    Krzyżek P; Franiczek R; Krzyżanowska B; Łaczmański Ł; Migdał P; Gościniak G
    Pathogens; 2019 Nov; 8(4):. PubMed ID: 31717683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In Vitro Activity of 3-Bromopyruvate, an Anticancer Compound, Against Antibiotic-Susceptible and Antibiotic-Resistant
    Krzyżek P; Franiczek R; Krzyżanowska B; Łaczmański Ł; Migdał P; Gościniak G
    Cancers (Basel); 2019 Feb; 11(2):. PubMed ID: 30781380
    [No Abstract]   [Full Text] [Related]  

  • 3. Myricetin as an Antivirulence Compound Interfering with a Morphological Transformation into Coccoid Forms and Potentiating Activity of Antibiotics against
    Krzyżek P; Migdał P; Paluch E; Karwańska M; Wieliczko A; Gościniak G
    Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33800082
    [No Abstract]   [Full Text] [Related]  

  • 4. Morphological and Bactericidal Effects of Different Antibiotics on Helicobacter pylori.
    Faghri J; Poursina F; Moghim S; Zarkesh Esfahani H; Nasr Esfahani B; Fazeli H; Mirzaei N; Jamshidian A; Ghasemian Safaei H
    Jundishapur J Microbiol; 2014 Jan; 7(1):e8704. PubMed ID: 25147656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ANTIBIOTIC RESISTANCE SURVEILLANCE OF HELICOBACTER PYLORI AT THE BIOBÍO REGION (CHILE) IN A DECADE.
    Parra-Sepúlveda C; Merino JS; Sáez-Carrillo K; González C; García-Cancino A
    Arq Gastroenterol; 2019; 56(4):361-366. PubMed ID: 31721972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential of Bacterial Cellulose Chemisorbed with Anti-Metabolites, 3-Bromopyruvate or Sertraline, to Fight against
    Krzyżek P; Gościniak G; Fijałkowski K; Migdał P; Dziadas M; Owczarek A; Czajkowska J; Aniołek O; Junka A
    Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33327555
    [No Abstract]   [Full Text] [Related]  

  • 7. [Changing patterns of antibiotic resistance of Helicobacter pylori in patients with peptic ulcer disease].
    Bang SY; Han DS; Eun CS; Kim JE; Ahn SB; Sohn JH; Jeon YC; Kang JO
    Korean J Gastroenterol; 2007 Dec; 50(6):356-62. PubMed ID: 18159172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Preliminary study on in-vitro induction of antibiotic resistance in Helicobacter pylori strains isolated from children].
    Yan WH; Chen J; Hu HJ; Yu JD; Huang XL; Li ZY
    Zhonghua Er Ke Za Zhi; 2007 Sep; 45(9):708-11. PubMed ID: 18021568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increase in resistance rates of H. pylori isolates to metronidazole and tetracycline--comparison of three 3-year studies.
    Siavoshi F; Saniee P; Latifi-Navid S; Massarrat S; Sheykholeslami A
    Arch Iran Med; 2010 May; 13(3):177-87. PubMed ID: 20433221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative in vitro antimicrobial susceptibility and synergistic activity of antimicrobial combinations against Helicobacter pylori isolates in Taiwan.
    Cheng A; Sheng WH; Liou JM; Wang HP; Wu MS; Lin JT; Chang SC
    J Microbiol Immunol Infect; 2015 Feb; 48(1):72-9. PubMed ID: 23036269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increasing antimicrobial resistance to clarithromycin and metronidazole in pediatric Helicobacter pylori infection in southern Taiwan: A comparison between two decades.
    Lu HH; Lai FP; Lo HY; Sheu BS; Yang YJ
    Helicobacter; 2019 Oct; 24(5):e12633. PubMed ID: 31295754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro activity of a novel antimicrobial agent, TG44, for treatment of Helicobacter pylori infection.
    Kamoda O; Anzai K; Mizoguchi J; Shiojiri M; Yanagi T; Nishino T; Kamiya S
    Antimicrob Agents Chemother; 2006 Sep; 50(9):3062-9. PubMed ID: 16940102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic Therapies as a Promising Option for the Treatment of Antibiotic-Resistant
    Krzyżek P; Paluch E; Gościniak G
    Antibiotics (Basel); 2020 Sep; 9(10):. PubMed ID: 33007899
    [No Abstract]   [Full Text] [Related]  

  • 14. Antibiofilm and Antimicrobial-Enhancing Activity of
    Krzyżek P; Junka A; Słupski W; Dołowacka-Jóźwiak A; Płachno BJ; Sobiecka A; Matkowski A; Chodaczek G; Płusa T; Gościniak G; Zielińska S
    Pathogens; 2021 Aug; 10(8):. PubMed ID: 34451497
    [No Abstract]   [Full Text] [Related]  

  • 15. Broad spectrum resistance in Helicobacter pylori isolated from gastric biopsies of patients with dyspepsia in Cameroon and efflux-mediated multiresistance detection in MDR isolates.
    Kouitcheu Mabeku LB; Eyoum Bille B; Tepap Zemnou C; Tali Nguefack LD; Leundji H
    BMC Infect Dis; 2019 Oct; 19(1):880. PubMed ID: 31640588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibiotic susceptibility of Helicobacter pylori clinical isolates: comparative evaluation of disk-diffusion and E-test methods.
    Mishra KK; Srivastava S; Garg A; Ayyagari A
    Curr Microbiol; 2006 Oct; 53(4):329-34. PubMed ID: 16972131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rifabutin and Furazolidone Could Be the Candidates of the Rescue Regimen for Antibiotic-Resistant
    Choi YI; Jeong SH; Chung JW; Park DK; Kim KO; Kwon KA; Kim YJ; So S; Lee JH; Jeong JY; Lee SM
    Can J Infect Dis Med Microbiol; 2019; 2019():9351801. PubMed ID: 31360270
    [No Abstract]   [Full Text] [Related]  

  • 18. Antimicrobial susceptibility of Helicobacter pylori strains isolated from children in Israel.
    Pastukh N; Peretz A; Brodsky D; Isakovich N; Azrad M; On A
    J Glob Antimicrob Resist; 2018 Mar; 12():175-178. PubMed ID: 29033302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial resistance of Helicobacter pylori strains to five antibiotics, including levofloxacin, in Northwestern Turkey.
    Caliskan R; Tokman HB; Erzin Y; Saribas S; Yuksel P; Bolek BK; Sevuk EO; Demirci M; Yılmazli O; Akgul O; Kalayci F; Cakan H; Salih B; Bal K; Kocazeybek B
    Rev Soc Bras Med Trop; 2015; 48(3):278-84. PubMed ID: 26108005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of antibiotic resistance of Helicobacter pylori isolates in Estonia during 1995-2000 in comparison to the consumption of antibiotics used in treatment regimens.
    Lõivukene K; Maaroos HI; Kolk H; Kull I; Labotkin K; Mikelsaar M
    Clin Microbiol Infect; 2002 Sep; 8(9):598-603. PubMed ID: 12427220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.